Fisetin Reduces Ovalbumin-triggered Airway Remodeling by Preventing Phenotypic Switching of Airway Smooth Muscle Cells

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2024 Oct 14

PMID 39402516

Authors

Yuanyuan Liu

Qiling Yin

Bin Liu

Zheng Lu

Meijun Liu

Ling Meng

Chao He

Jin Chang

Affiliations

Soon will be listed here.

Abstract

Background: The transformation of airway smooth muscle cells (ASMCs) from a quiescent phenotype to a hypersecretory and hypercontractile phenotype is a defining feature of asthmatic airway remodeling. Fisetin, a flavonoid compound, possesses anti-inflammatory characteristics in asthma; yet, its impact on airway remodeling and ASMCs phenotype transition has not been investigated.

Objectives: This research seeked to assess the impact of fisetin on ovalbumin (OVA) induced asthmatic airway remodeling and ASMCs phenotype transition, and clarify the mechanisms through network pharmacology predictions as well as in vivo and in vitro validation.

Methods: First, a fisetin-asthma-ASMCs network was constructed to identify potential targets. Subsequently, cellular and animal studies were carried out to examine the inhibitory effects of fisetin on airway remodeling in asthmatic mice, and to detemine how fisetin impacts the phenotypic transition of ASMCs.

Results: Network analysis indicated that fisetin might affect asthma via mediating the phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (AKT) pathway. Intraperitoneal administration of fisetin in vivo reduced airway inflammation and remodeling, as shown by reduced inflammatory cells, decreased T helper type 2 (Th2) cytokine release, diminished collagen accumulation, mitigated airway smooth muscle thickening, and decreased expression of osteopontin (OPN), collagen-I and α-smooth muscle actin (α-SMA). Moreover, fisetin suppressed the PI3K/AKT pathway in asthmatic lung tissue. According to the in vitro data, fisetin downregulated the expression of the synthetic phenotypic proteins OPN and collagen-I, contractile protein α-SMA, and inhibited cellular migration, potentially through the PI3K/AKT pathway.

Conclusion: These results suggest that fisetin inhibits airway remodeling in asthma by regulating ASMCs phenotypic shift, emphasizing that fisetin is a promising candidate for the treatment of airway smooth muscle remodeling.

References

Ashkar S, Weber G, Panoutsakopoulou V, Sanchirico M, Jansson M, Zawaideh S . Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 2000; 287(5454):860-4. DOI: 10.1126/science.287.5454.860. View

Khan N, Syed D, Ahmad N, Mukhtar H . Fisetin: a dietary antioxidant for health promotion. Antioxid Redox Signal. 2012; 19(2):151-62. PMC: 3689181. DOI: 10.1089/ars.2012.4901. View

Daina A, Michielin O, Zoete V . SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019; 47(W1):W357-W364. PMC: 6602486. DOI: 10.1093/nar/gkz382. View

Winkler T, Frey U . Airway remodeling: Shifting the trigger point for exacerbations in asthma. J Allergy Clin Immunol. 2021; 148(3):710-712. DOI: 10.1016/j.jaci.2021.07.010. View

Xu G, Yang K, Xu Z, Zhu L, Hou L, Qi H . Protective effects of anisodamine on cigarette smoke extract-induced airway smooth muscle cell proliferation and tracheal contractility. Toxicol Appl Pharmacol. 2012; 262(1):70-9. DOI: 10.1016/j.taap.2012.04.020. View

Wright D, Trian T, Siddiqui S, Pascoe C, Johnson J, Dekkers B . Phenotype modulation of airway smooth muscle in asthma. Pulm Pharmacol Ther. 2012; 26(1):42-9. DOI: 10.1016/j.pupt.2012.08.005. View

De Vries T, de Langen-Wouterse J, van Puijenbroek E, Duiverman E, de Jong-van den Berg L . Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands. Eur J Clin Pharmacol. 2006; 62(5):343-6. DOI: 10.1007/s00228-006-0102-6. View

Gela A, Kasetty G, Morgelin M, Bergqvist A, Erjefalt J, Pease J . Osteopontin binds and modulates functions of eosinophil-recruiting chemokines. Allergy. 2015; 71(1):58-67. DOI: 10.1111/all.12771. View

Brown A, Danielsson J, Townsend E, Zhang Y, Perez-Zoghbi J, Emala Sr C . Attenuation of airway smooth muscle contractility via flavonol-mediated inhibition of phospholipase-Cβ. Am J Physiol Lung Cell Mol Physiol. 2016; 310(8):L747-58. PMC: 4836109. DOI: 10.1152/ajplung.00215.2015. View

10.

Wang H, Zhong B, Geng Y, Hao J, Jin Q, Zhang Y . TIPE2 inhibits PDGF-BB-induced phenotype switching in airway smooth muscle cells through the PI3K/Akt signaling pathway. Respir Res. 2021; 22(1):238. PMC: 8393827. DOI: 10.1186/s12931-021-01826-5. View

11.

Savin I, Zenkova M, Senkova A . Bronchial Asthma, Airway Remodeling and Lung Fibrosis as Successive Steps of One Process. Int J Mol Sci. 2023; 24(22). PMC: 10671561. DOI: 10.3390/ijms242216042. View

12.

Slats A, Janssen K, van Schadewijk A, van der Plas D, Schot R, van den Aardweg J . Expression of smooth muscle and extracellular matrix proteins in relation to airway function in asthma. J Allergy Clin Immunol. 2008; 121(5):1196-202. DOI: 10.1016/j.jaci.2008.02.017. View

13.

Ma L, Zhang R, Li D, Qiao T, Guo X . Fluoride regulates chondrocyte proliferation and autophagy via PI3K/AKT/mTOR signaling pathway. Chem Biol Interact. 2021; 349:109659. DOI: 10.1016/j.cbi.2021.109659. View

14.

Kashyap D, Garg V, Tuli H, Yerer M, Sak K, Sharma A . Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential. Biomolecules. 2019; 9(5). PMC: 6572624. DOI: 10.3390/biom9050174. View

15.

Adhami V, Syed D, Khan N, Mukhtar H . Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. Biochem Pharmacol. 2012; 84(10):1277-81. PMC: 3813433. DOI: 10.1016/j.bcp.2012.07.012. View

16.

Khalfaoui L, Pabelick C . Airway smooth muscle in contractility and remodeling of asthma: potential drug target mechanisms. Expert Opin Ther Targets. 2023; 27(1):19-29. PMC: 10208413. DOI: 10.1080/14728222.2023.2177533. View

17.

Vlahos C, Matter W, Hui K, Brown R . A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994; 269(7):5241-8. View

18.

An Z, Liu Y, Song Z, Tang H, Yuan Y, Xu Z . Mechanisms of aortic dissection smooth muscle cell phenotype switch. J Thorac Cardiovasc Surg. 2017; 154(5):1511-1521.e6. DOI: 10.1016/j.jtcvs.2017.05.066. View

19.

Huang W, Li M, Xia M, Shao J . Fisetin-treatment alleviates airway inflammation through inhbition of MyD88/NF-κB signaling pathway. Int J Mol Med. 2018; 42(1):208-218. PMC: 5979929. DOI: 10.3892/ijmm.2018.3582. View

20.

Amberger J, Bocchini C, Schiettecatte F, Scott A, Hamosh A . OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2014; 43(Database issue):D789-98. PMC: 4383985. DOI: 10.1093/nar/gku1205. View